West Pharmaceutical Services, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US9553061055
USD
327.95
4.36 (1.35%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
DexCom, Inc.
IDEXX Laboratories, Inc.
Medtronic Plc
Intuitive Surgical, Inc.
Edwards Lifesciences Corp.
Agilent Technologies, Inc.
West Pharmaceutical Services, Inc.
Stryker Corp.
Danaher Corp.
GE Healthcare Technologies, Inc.
Becton, Dickinson & Co.

Why is West Pharmaceutical Services, Inc. ?

1
High Management Efficiency with a high ROE of 22.89%
2
Company has a low Debt to Equity ratio (avg) at times
3
Healthy long term growth as Operating profit has grown by an annual rate 12.66%
4
Flat results in Jun 25
  • OPERATING CASH FLOW(Y) Lowest at USD 676.7 MM
5
With ROE of 18.49%, it has a fair valuation with a 6.12 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -14.35%, its profits have fallen by -14%
6
Below par performance in long term as well as near term
  • Along with generating -14.35% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to West Pharmaceutical Services, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is West Pharmaceutical Services, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
West Pharmaceutical Services, Inc.
50.47%
-0.26
56.15%
S&P 500
25.41%
0.70
20.15%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
7.45%
EBIT Growth (5y)
8.59%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
0.97
Tax Ratio
20.26%
Dividend Payout Ratio
12.66%
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
32.01%
ROE (avg)
22.89%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
34
Industry P/E
Price to Book Value
5.61
EV to EBIT
27.10
EV to EBITDA
21.35
EV to Capital Employed
6.61
EV to Sales
5.61
PEG Ratio
7.67
Dividend Yield
0.35%
ROCE (Latest)
24.37%
ROE (Latest)
16.61%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company
INVENTORY TURNOVER RATIO(HY)

Highest at 4.88 times

DIVIDEND PER SHARE(HY)

Highest at USD 5.07

NET SALES(Q)

Highest at USD 844.6 MM

OPERATING PROFIT(Q)

Highest at USD 227.9 MM

PRE-TAX PROFIT(Q)

Highest at USD 184.5 MM

RAW MATERIAL COST(Y)

Fallen by -5.51% (YoY

-12What is not working for the Company
INTEREST COVERAGE RATIO(Q)

Lowest at 11,994.74

INTEREST(Q)

Highest at USD 1.9 MM

Here's what is working for West Pharmaceutical Services, Inc.

Net Sales
Highest at USD 844.6 MM and Grown
In each period in the last five periods
MOJO Watch
Near term sales trend is very positive

Net Sales (USD MM)

Operating Profit
Highest at USD 227.9 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (USD MM)

Pre-Tax Profit
Highest at USD 184.5 MM and Grown
In each period in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (USD MM)

Inventory Turnover Ratio
Highest at 4.88 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Dividend per share
Highest at USD 5.07 and Grown
In each year in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (USD)

Raw Material Cost
Fallen by -5.51% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for West Pharmaceutical Services, Inc.

Interest
At USD 1.9 MM has Grown at inf%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Interest Coverage Ratio
Lowest at 11,994.74
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Interest
Highest at USD 1.9 MM
in the last five periods and Increased by inf% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Non Operating Income
Highest at USD 0.02 MM
in the last five periods
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating income